Dostarlimab with platinum-based chemotherapy for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency
Technology appraisal guidance
Reference number: TA1064
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.